The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, CryoPort Inc’s stock clocked out at $6.74, up 2.43% from its previous closing price of $6.58. In other words, the price has increased by $2.43 from its previous closing price. On the day, 0.5 million shares were traded. CYRX stock price reached its highest trading level at $6.9 during the session, while it also had its lowest trading level at $6.42.
Ratios:
To gain a deeper understanding of CYRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.24 and its Current Ratio is at 5.56. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.56.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.
Jefferies Downgraded its Buy to Hold on August 07, 2024, whereas the target price for the stock was revised from $20 to $8.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 24 ’25 when Sawicki Mark W sold 1,349 shares for $6.94 per share. The transaction valued at 9,364 led to the insider holds 84,087 shares of the business.
STEFANOVICH ROBERT sold 1,070 shares of CYRX for $7,428 on Mar 24 ’25. The Chief Financial Officer now owns 190,349 shares after completing the transaction at $6.94 per share. On Mar 24 ’25, another insider, SHELTON JERRELL, who serves as the President, CEO of the company, sold 2,980 shares for $6.94 each. As a result, the insider received 20,686 and left with 762,419 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 337924704 and an Enterprise Value of 372836864. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.57 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 1.606 whereas that against EBITDA is -11.425.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.89, which has changed by -0.41493058 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $12.58, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is 11.79%, while the 200-Day Moving Average is calculated to be -6.57%.
Shares Statistics:
It appears that CYRX traded 539.17K shares on average per day over the past three months and 557940 shares per day over the past ten days. A total of 50.14M shares are outstanding, with a floating share count of 48.29M. Insiders hold about 3.69% of the company’s shares, while institutions hold 92.53% stake in the company. Shares short for CYRX as of 1745971200 were 2648061 with a Short Ratio of 4.91, compared to 1743379200 on 2443367. Therefore, it implies a Short% of Shares Outstanding of 2648061 and a Short% of Float of 6.34.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
